NADINE - NAnosystems for early DIagnosis of NEurodegenerative Diseases

The NADINE project aims at the development of a diagnostic tool able to detect in blood as early as possible, and at a cost compatible with large scale screening, an emerging neurodegenerative disease, and thus aid in the selection the best treatment. The project involves a multidisciplinary consortium of technology developers, three leading biomedical groups in clinical neuroscience for definition of specifications and end-user pre-clinical validation, three research-oriented SMEs in biotechnology, nanosensing and microfluidics and a pharmaceutical company.